The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: The renal insufficiency and anticancer medications (IRMA) study
Abstract
BACKGROUND.: The Renal Insufficiency and Cancer Medications (IRMA) study is a French national observational study. The results from this study of nearly 5000 patients demonstrated the high prevalence of renal impairment in a population of patients with solid tumors. METHODS.: Every cancer patient who presented at oncology departments that participated in the study over at least 1 of 2 predefined periods during 2004 were included. Renal function was calculated using Cockcroft‐Gault and abbreviated Modification of Diet in Renal Disease (aMDRD) formulae to estimate the prevalence of renal insufficiency (RI) according to the Kidney Disease Outcomes Quality Initiative‐Kidney Disease Improving Global Outcomes definition and stratification. Anticancer drugs were studied with regard to their potential renal toxicity and dosage adjustment. RESULTS.: Of the 4684 patients from the 15 centers, 7.2% had serum creatinine levels >110 μmol/L. However, when they were assessed using Cockcroft‐Gault and aMDRD formulae, 57.4% and 52.9% of patients had abnormal renal function or RI, respectively. Of the 7181 anticancer drug prescriptions, 53.4% required dose adjustments for RI. Of the patients treated, 79.9% received at least 1 such drug. And 80.1% received potentially nephrotoxic drugs. CONCLUSIONS.: RI was common in patients with cancer, and drug dosage adjustments often were necessary. Renal function should be evaluated in all cancer patients using either the Cockcroft‐Gault formula or the aMDRD formula, including patients with normal serum creatinine levels. In patients who are at high risk for drug toxicity, the dosage should be adapted to renal function, and the use of nephrotoxic therapies should be avoided whenever possible. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
Calvert, A. H., Newell, D. R., Gumbrell, L. A., O'Reilly, S., Burnell, M., Boxall, F. E., Siddik, Z. H., Judson, I. R., Gore, M. E., & Wiltshaw, E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.11.1748 · Cited by 1,866
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6
Ruddle, F. H., & Meera Khan, P. (1976) · Cytogenetic and Genome Research · doi:10.1159/000130554 · Cited by 845
Froissart, M., Rossert, J., Jacquot, C., Paillard, M., & Houillier, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070549 · Cited by 803
Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey
Jones, C., McQuillan, G., Kusek, J., Eberhardt, M., Herman, W., Coresh, J., Salive, M., Jones, C., & Agodoa, L. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70074-5 · Cited by 572
The Physicians' Desk Reference: Problems and Possible Improvements
Cohen, J. S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440120021003 · Cited by 428
Verhave, J. C., Fesler, P., Ribstein, J., du Cailar, G., & Mimran, A. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.011 · Cited by 386
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-502_4 · Cited by 360
Drug-induced acute kidney injury
Schetz, M., Dasta, J., Goldstein, S., & Golper, T. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000184300.68383.95 · Cited by 313
VUAGNIAUX, G., VALLET, V., JAEGER, N. F., PFISTER, C., BENS, M., FARMAN, N., COURTOIS-COUTRY, N., VANDEWALLE, A., ROSSIER, B. C., & HUMMLER, E. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v115828 · Cited by 221
Increased incidence of neoplasia in chronic renal failure (20-year experience)
Cengiz, K. (2002) · International Urology and Nephrology · doi:10.1023/a:1014489911153 · Cited by 90
Drug prescribing in renal failure: Dosing guidelines for adults
Matzke, G. R. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70132-0 · Cited by 78
Cited by
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Brown, J. E., Yardley, D. A., Richardson, G. E., Siena, S., Maroto, P., Clemens, M., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.08.002 · Cited by 588
Self-citationTumor-Induced NETosis as a Risk Factor for Metastasis and Organ Failure
Cedervall, J., Zhang, Y., & Olsson, A.-K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3051 · Cited by 146
Evaluation of cystatin C in malignancy and comparability of estimates of GFR in oncology patients
Jones, M., Denieffe, S., Griffin, C., Tinago, W., & Fitzgibbon, M. C. (2017) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2017.05.005 · Cited by 46
Metadata
- Authors
- Launay‐Vacher, V., Oudard, S., Janus, N., Gligorov, J., Pourrat, X., Rixe, O., Morere, J., Beuzeboc, P., Deray, G., & On behalf of the Renal Insufficiency and Cancer Medications (IRMA) Study Group
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-08-31
- Volume
- 110
- Issue
- 6
- Pages
- 1376-1384
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1982379324
- Cited by
- 458
- References
- 15
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.